Biosimilars and the Patient Perspective

Welcome to GHAPPcast, the official podcast for gastroenterology and hepatology advanced practice providers. Hosted by Gabriella McCarty, a nurse practitioner at NorthShore Gastroenterology in Cleveland, this episode dives into a crucial topic—biosimilars from a patient’s perspective. As a founding member of GHAPP and a provider with 25 years of experience in general GI, IBD, and hepatology, Gabriella is excited to explore the real-world impact of biosimilars through the eyes of a patient.

In this episode, we welcome Emily, a Crohn’s disease patient who has firsthand experience transitioning to and from biosimilars. She shares her journey, initial concerns, and how switching medications impacted her health. With insurance-driven transitions from Remicade to Inflectra and back, Emily provides valuable insights into the realities of biosimilar treatment, debunking misconceptions, and highlighting the importance of open communication with healthcare providers.

For patients, providers, and caregivers navigating biosimilar treatments, this discussion offers a unique perspective on the transition process, medication efficacy, and long-term remission maintenance. Whether you’re a clinician seeking to guide patients or someone facing a biosimilar switch, this episode provides essential takeaways for ensuring a smooth and informed treatment journey.

Subscribe to GHAPP for more expert insights into gastroenterology, hepatology, IBD, and patient-centered care. Visit ghapp.org and download the GHAPP ACE app for more educational content.